EuroIntervention PCRonline - Connecting with the community

Azeem Latib

56 articles

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

EuroIntervention 2017;12:2110-2117 published online ahead of print March 2017

Published in Volume 12 Number 17, April 2017

12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry

EuroIntervention 2017; just accepted article published in March 2017

Everolimus Eluting Bioresorbable Vascular Scaffold for Treatment of Complex Chronic Total Occlusions

EuroIntervention 2017; just accepted article published in February 2017

How should I treat recurrent restenosis with underexpanded multilayered struts after repeated complex bifurcation stenting?

EuroIntervention 2017;12:1795-1798

Published in Volume 12 Number 14, February 2017

Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy

EuroIntervention 2017;12:1730-1737 published online October 2016

Published in Volume 12 Number 14, February 2017

The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation

EuroIntervention 2016;12:1542-1549

Published in Volume 12 Number 12, December 2016

ROTational AThErectomy in acute coronary syndrome: early and midterm outcomes from a multicentre registry

EuroIntervention 2016;12:1457-1464

Published in Volume 12 Number 12, December 2016

In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation: the ROTATE multicentre registry

EuroIntervention 2016;12:1448-1456

Published in Volume 12 Number 12, December 2016

High-risk left main percutaneous coronary intervention supported by pressure-controlled intermittent coronary sinus occlusion

EuroIntervention 2016;12:e1437 published online e-edition December 2016

Published in Volume 12 Number 11, December 2016

A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis

EuroIntervention 2016;12:e1413-e1419 published online e-edition December 2016

Published in Volume 12 Number 11, December 2016

TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery

EuroIntervention 2016;12:Y22-Y27

Published in Volume 12 Supplement Y, September 2016

Percutaneous repair of the tricuspid valve using a novel cinching device: acute and chronic experience in a preclinical large animal model

EuroIntervention 2016;12:918-925

Published in Volume 12 Number 7, September 2016

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment

EuroIntervention 2016;12:e623-e631 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry

EuroIntervention 2016;12:e550-e556 published online ahead of print September 2015 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Anaesthetic management of transcatheter aortic valve implantation: results from the Italian CoreValve registry

EuroIntervention 2016;12:381-388 published online ahead of print March 2015

Published in Volume 12 Number 3, June 2016

The drive towards standardised clinical study endpoints in transcatheter aortic valve interventions

EuroIntervention 2016;12:299-300

Published in Volume 12 Number 3, June 2016

Clinical outcomes following “off-label” versus “established” indications of bioresorbable scaffolds for the treatment of coronary artery disease in a real-world population

EuroIntervention 2016;11:1475-1478

Published in Volume 11 Number 13, April 2016

Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience

EuroIntervention 2016;11:e1589-e1595 published online e-edition April 2016

Published in Volume 11 Number 14, April 2016

The use of a scoring balloon for optimal lesion preparation prior to bioresorbable scaffold implantation: a comparison with conventional balloon predilatation

EuroIntervention 2016;11:e1580-e1588 published online e-edition April 2016

Published in Volume 11 Number 14, April 2016

Preprocedural planning and implantation of a transcatheter aortic valve without the use of contrast agent

EuroIntervention 2016;11:1433 published online ahead of print July 2015

Published in Volume 11 Number 12, March 2016

Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds

EuroIntervention 2016;11:1355-1362 published online ahead of print March 2015

Published in Volume 11 Number 12, March 2016

First-in-man transcatheter mitral valve-in-ring implantation with a repositionable and retrievable aortic valve prosthesis

EuroIntervention 2016;11:1148-1152 published online ahead of print November 2015

Published in Volume 11 Number 10, February 2016

Real-world multicentre experience with the Direct Flow Medical® repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis

EuroIntervention 2016;11:e1314-e1320 published online e-edition February 2016

Published in Volume 11 Number 11, February 2016

Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations

EuroIntervention 2016;11:989-995 published online ahead of print November 2014

Published in Volume 11 Number 9, January 2016

Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective

EuroIntervention 2015;11:45-52 published online ahead of print January 2015

Published in Volume 11 Number 1, May 2015

Lessons from the GHOST-EU registry

EuroIntervention 2015;11:V170-V174

Published in Volume 11 Supplement V, May 2015

Coronary bifurcations as you have never seen them: the Visible Heart® Laboratory bifurcation programme

EuroIntervention 2015;11:V40-V43

Published in Volume 11 Supplement V, May 2015

Preliminary outcomes after transcatheter aortic valve implantation in patients with systemic sclerosis

EuroIntervention 2015;10:1464-1467

Published in Volume 10 Number 12, April 2015

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

EuroIntervention 2015;10:1144-1153 published online ahead of print July 2014

Published in Volume 10 Number 10, February 2015

How should I treat progression of disease of the jailed left anterior descending ostium after bioresorbable vascular scaffold implantation in the left circumflex?

AsiaIntervention 2015;1:81-88

Published in Asiaintervention Volume 1 Issue 1, January 2015

Clinical outcomes of MitraClip for the treatment of functional mitral regurgitation

EuroIntervention 2014;10:746-752 published online ahead of print January 2014

Published in Volume 10 Number 6, October 2014

CoreValve implantation for severe aortic regurgitation: a multicentre registry

EuroIntervention 2014;10:739-745

Published in Volume 10 Number 6, October 2014

Is it time to simplify the TAVI procedure? “Make it simple but not too simple”

EuroIntervention 2014;10:U22-U27

Published in Volume 10 Supplement U, September 2014

Tools and Techniques – Clinical: The inner curve technique for implantation of the Direct Flow Medical® transcatheter aortic valve

EuroIntervention 2014;10:400-402

Published in Volume 10 Number 3, July 2014

Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project

EuroIntervention 2014;10:133-140 published online ahead of print November 2013

Published in Volume 10 Number 1, May 2014

Two-year outcomes following unprotected left main stenting with first vs. new-generation drug-eluting stents: the FINE registry

EuroIntervention 2013;9:809-816

Published in Volume 9 Number 7, November 2013

Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry

EuroIntervention 2013;9:803-808

Published in Volume 9 Number 7, November 2013

Transseptal access for MitraClip® procedures using surgical diathermy under echocardiographic guidance

EuroIntervention 2012;8:579-586 published online ahead of print June 2012

Published in Volume 8 Number 5, September 2012

Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidates

EuroIntervention 2012;8:429-436

Published in Volume 8 Number 4, August 2012

Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience

EuroIntervention 2012;7:1275-1284 publish online ahead of print January 2012

Published in Volume 7 Number 11, March 2012

Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world experience

EuroIntervention 2012;7:1170-1180

Published in Volume 7 Number 10, February 2012

The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry

EuroIntervention 2011;7:556-563

Published in Volume 7 Number 5, September 2011

A high dose of adenosine to induce transient asystole for valvuloplasty in patients undergoing TAVI: is it a valid alternative to rapid pacing? A prospective pilot study

Published in Volume 7 Supplement M, May 2011

Valve-in-valve procedure with the Edwards transcatheter heart valve to treat bioprosthetic valve degeneration in high-risk surgical patients

Published in Volume 7 Supplement M, May 2011

Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation

Published in Volume 7 Supplement M, May 2011

A comparison of transfemoral TAVI and surgical aortic valve replacement in high-risk elderly patients with severe aortic stenosis

Published in Volume 7 Supplement M, May 2011

Outcomes Following TAVI with both Edwards SAPIEN and CoreValve devices in a single centre: the on-going Milan Experience

Published in Volume 7 Supplement M, May 2011

Comparison of Everolimus- vs. first generation DES In left main coronary artery lesions: the HSR-EMO experience

Published in Volume 7 Supplement M, May 2011

Clinical outcomes in diabetic and non-diabetic patients treated with Endeavor Resolute Zotarolimus eluting-stent: a multicentre Italian observational study

Published in Volume 7 Supplement M, May 2011

Safety of dual antiplatelet therapy interruption after Resolute stent implantation: an Italian multicentre observational evaluation

Published in Volume 7 Supplement M, May 2011

Treatment of iatrogenic occlusive coronary dissections: a novel approach

EuroIntervention 2011;6:106-111

Published in Volume 7 Number 1, May 2011

The Cappella Sideguard™ stent

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J143-J146

Published in Volume 6 Supplement J, December 2010

When are two stents needed? Which technique is the best? How to perform?

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J81-J87

Published in Volume 6 Supplement J, December 2010

Long-term outcomes following percutaneous intervention with multiple drug-eluting stent implantation in patients with low, intermediate and high SYNTAX scores

Published in Volume 6 Supplement H, May 2010

Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry)

EuroIntervention 2010;5:906-916 - DOI10.4244/EIJV5I8A154

Published in Volume 5 Number 8, April 2010

Comments on the article by Routledge et al "Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)"

EuroIntervention 2010;5:875-876

Published in Volume 5 Number 7, February 2010